Click here and follow the step-by-step guide to create your account and enroll in courses.Enrollment Guide
QUESTIONS or TECHNICAL ISSUES?
Contact: 202-232-6749 or elearning@healthhiv.org
- ModuleLearning ObjectivesAccreditation Details
- Acupuncture, Massage, and Self-Care
Open this module→- Explain the risks and benefits of acupuncture and massage therapies
- Explain the role of acupuncture and massage in comprehensive pain management
- Name three (3) conditions for which acupuncture is recommended in practice guidelines
- Describe two (2) self care techniques
February 9, 2022Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-056-H04-P
Knowledge - After the Waiver: Translating Training Into Practice, Advanced Topics in Buprenorphine
Open this module→- Simplify the buprenorphine induction process to make it feasible in their practice
- Address difficulties that may occur over the course of treating patients with buprenorphine
- Develop psychosocial treatment plans that are tailored to patient needs
- Manage unanticipated events such as injury and pregnancy in patients on buprenorphine
- Name two (2) resources that can provide additional support for buprenorphine prescribers as they encounter complexities in patient care
February 9, 2022Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-057-H04-P
Knowledge - Assessing Opioid Use Disorder: Selecting Appropriate Tools
Open this module→- Explain the recommended stepwise approach to identifying opioid use disorder
- Utilize available tools for assessing both substance use and opioid use disorder
- Identify a tool for assessing substance use disorder into practice, making modifications as necessary for your setting
January 26, 2021Expiration Date:
January 25, 2022
UAN #:
JA4008162-9999-20-2482-H01-P
Application - Cocaine and Methamphetamine Use: Strategies for Addressing Acute Intoxication and WithdrawalOpen this module→
- Explain the current state of stimulant use disorder and its public health burden
- Recognize the long-term impact, signs and symptoms of stimulant intoxication, withdrawal, and overdose
- Identify evidence-based treatment options for stimulant use disorder
September 7, 2022Expiration Date:
September 6, 2023
UAN #:
N/A
Knowledge - Cognitive Behavioral Therapy (CBT) & Mind-Body Techniques in Addressing Pain
Open this module→- List three (3) mind body strategies that are helpful for pain patients
- Instruct a patient in one breathing exercise
- Describe central sensitization and indicate three (3) risk factors that predispose an individual to it
February 9, 2022Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-058-H04-P
Knowledge - Development and Implementation of Evidence-Based Opioid Prescribing Guidelines for Surgical Patients
Open this module→- Summarize the risks and benefits of opioids prescribed for acute surgical pain
- Evaluate the existing CDC opioid prescribing guidelines in light of current evidence
- Describe Mayo Clinic’s historical surgical prescribing practices and patient-reported opioid consumption
- Recognize how multidisciplinary teams developed and implemented prescribing guidelines
- Describe how to access the publicly-available Mayo Clinic guidelines for opioid prescribing at discharge from surgery
October 8, 2020Expiration Date:
October 7, 2021
UAN #:
JA4008162-9999-20-2371-H01-P
Knowledge - Effective Opioid Tapering
Open this module→- Discuss the risks and benefits of opioid tapering
- Apply evidence-based strategies when tapering opioids
- Explain main steps involved in preparing for, initiating, and continually assessing opioid tapering
January 26, 2021Expiration Date:
January 25, 2022
UAN #:
JA4008162-9999-20-2483-H01-P
Application - Enhancing Organizational Capacity and Provider Readiness to Treat OUD With Buprenorphine/Naloxone: Clinical Application of a MOUD
Open this module→- Detail how to treat OUD with buprenorphine/naloxone
- List at least two justifications for the use of combination buprenorphine/naloxone as the standard of care for general use
- List at least three methods for establishing community partnerships and promoting MOUD services in general medical settings
- Describe the key principles of the medication first model
- Discuss the benefit of adding psychosocial support to the treatment of patients receiving MOUD
- Employ appropriate urine toxicology strategies
- Outline treatment considerations for patients with co-occurring psychiatric disorders
- Explain how to conduct a Telehealth session for treatment of OUDs
February 9, 2022Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-059-H04-P
Knowledge - Enhancing Organizational Capacity and Provider Readiness to Treat OUD With Buprenorphine/Naloxone: System Level Strategies
Open this module→- List at least four overlapping characteristics of successful MOUD models of care
- Describe the necessary organizational and clinical changes needed to address drug
use in primary care settings - Apply the roadmap (plan, do, study, act) to implement quality improvement processes
for each of the five key clinical changes necessary in addressing substance use
disorders - Differentiate between language and phrasing that focused on the person from disease-
based language - Address workflow considerations in the identification and management of OUDs
- Discuss the role of motivational interviewing in addressing the treatment of OUDs
with patients - Define the collaborative care model
October 22, 2020Expiration Date:
October 21, 2021
UAN #:
JA4008162-9999-20-2406-H01-P
Application - Epidemiology of OUD: the US and the District
Open this module→- Describe the current spread of opioid use and overdoses across the US and within the District
- Detail the common demographics of people living with OUD in DC
- List the main drugs utilized by people living with OUD
- Explain the regional needs for services for people living with OUD
October 8, 2020Expiration Date:
October 7, 2021
UAN #:
JA4008162-9999-20-2372-H01-P
Knowledge - Evidence-Based Practices for Treating Stimulant Use DisorderOpen this module→
- Identify common trends and issues impacting the treatment of individuals with stimulant use disorder
- Discuss the current and emerging evidence behind pharmacological treatment of stimulant use disorder
- Identify and discuss the efficacy of psychosocial interventions for use in treatment of stimulant use disorder
- Identify the most effective approaches to inform clinical practice in treatment of ongoing stimulant use disorders
September 7, 2022Expiration Date:
September 6, 2023
UAN #:
N/A
N.A. - Harm Reduction Approaches for Providers Addressing Opioid Use
Open this module→- Define Harm Reduction
- Identify factors that impact patient-provider relationships
- Describe Harm Reduction techniques for patient-centered clinical conversations
- Identify specific Harm Reduction strategies for patients who use opioids
- Apply Harm Reduction strategies to a case scenario
Activity Release Date:
October 8, 2020Expiration Date:
October 7, 2021
UAN #:
JA4008162-9999-20-2373-H01-P
Knowledge - Identifying and Treating Stimulant Use Disorder: Clinical Syndromes of Acute and Chronic Stimulant UseOpen this module→
- Identify behavioral and physiological symptoms of acute and chronic stimulant use.
- Discuss best practices in screening and assessing for stimulant use disorder.
- Present strategies for early intervention and for addressing chronic stimulant use.
- Identify examples of de-escalating stimulant intoxication, agitation, and psychosis.
September 7, 2022Expiration Date:
September 6, 2023
UAN #:
N/A
N.A. - Implementing the 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain
Open this module→- Describe the historical background and rationale for the CDC chronic opioid guidelines
- Discuss when to initiate, continue or discontinue opioids for chronic pain
- Plan how to select an opioid, dose, and follow persons on chronic opioid treatment
- Outline strategies for risk assessment and addressing harms of opioid use
October 8, 2020Expiration Date:
October 7, 2021
UAN #:
JA4008162-9999-20-2374-H01-P
Knowledge - Integrating Buprenorphine Treatment Into Infectious Disease Settings
Open this module→- Relate the epidemiology of opioid use disorder (OUD) and impact on infectious disease epidemics
- Describe the use of medication treatment for OUD (MOUD) for treatment of OUD and importantly the use of buprenorphine
- Discuss the considerations for the management of OUD and infectious disease treatment
- Review the NASEM recommendations published January 2020 to address barriers to integration of infectious disease and OUD prevention and treatment services
October 28, 2020Expiration Date:
October 27, 2021
UAN #:
JA4008162-9999-20-2435-H01-P
Knowledge - Needs of Returning Citizens with Substance Use Disorders
Open this module→- Identify the physical health, mental health, and social needs of citizens with substance use disorders returning to their Washington, D.C. communities following incarceration
- Discuss the existing resources available to returning citizens in Washington, D.C.
- Assess common barriers faced by returning citizens that impede their successful reintegration into their communities
- Consider policy changes that could remediate these barriers and facilitate successful transition back into the community
May 18, 2022Expiration Date:
May 17, 2023
UAN #:
N/A
Knowledge - Nutrition for Pain Management
Open this module→- Discuss three dietary changes that will benefit pain patients
- Discuss two changes in physiology that enable dietary modifications to improve health and pain
- Counsel patients on preliminary dietary changes for pain
February 9, 2020Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-060-H04-P
Knowledge - Opioid Overdose Prevention & Naloxone Education
Open this module→- List the names of common opioids
- Identify an opioid overdose and the steps to administer naloxone to reverse an overdose
- Describe the laws surrounding carrying and administering naloxone and other protections provided when seeking emergency medical help under safe reporting overdose laws
- Identify clinical best practices for working with patients who may have opioid use disorder
April 25, 2022Expiration Date:
April 25, 2023
UAN #:
JA4008162-9999-22-227-H01-P
Application
Open this module→- Name the three important areas of consideration when addressing opioid use
- Name at least two challenges to address opioid disorders with patient
- Elaborate on at least two types of provider-patient relationships
October 8, 2020Expiration Date:
October 7, 2021
UAN #:
JA4008162-9999-20-2377-H01-P
Knowledge
- Identify common trends and issues regarding prescription (Rx) stimulant misuse and abuse
- Discuss ways practitioners can identify signs of prescription stimulant abuse
- List ways those on the health care team can combat prescription stimulant misuse and abuse
- Identify interventions for use in treatment of stimulant use disorder
September 7, 2022Expiration Date:
September 6, 2023
UAN #:
N/A
N.A.
- Identify the epidemiology and presentation of stimulant induced psychosis
- Discuss the diagnosis, management, treatment, and treatment responses of acute amphetamine induced psychosis
- Identify best practices for ongoing care of chronic amphetamine psychosis
September 7, 2022Expiration Date:
September 6, 2023
UAN #:
N/A
N.A.
Open this module→- List the relative effectiveness of common pain medications
- Indicate the common side effects of available pain medications
- Describe the public health effects and costs of opioid prescriptions for acute pain
- Identify the four (4) main mechanisms of pain and their impact on acute pain
- Differentiate outcomes between common pain medications and opioid medications in managing acute pain
February 9, 2022Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-061-H04-P
Knowledge
Open this module→- Define the criteria for the diagnosis of OUD
- Explain why SNF facilities and administrators may be reluctant to bring patients and residents with substance use disorders into their buildings
- List the states where Prescription Drug Monitoring Programs (PDMPs) are operational
- Describe key techniques associated with successful psychotherapy with people with substance use problems
- Identify the ways in which SNF facilities can ensure the safety of all residents and staff
April 27, 2022
UAN #:
N/A
Application
Open this module→- Explain the chronic disease model of opioid use disorder (OUD)
- Discuss the risks and benefits of medications that are available to treat OUD
- Describe the fundamentals of medications treatment for OUD
- Begin to develop partnerships with local substance use treatment programs
- Choose a buprenorphine waiver training program that fits their needs and the needs of their patients
February 9, 2022Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-062-H04-P
Knowledge
Open this module→- Describe the clinical implications of stimulant use by individuals with opioid use
disorder (OUD) - Utilize strategies for detecting clinically significant stimulant use by patients in
treatment for OUD - Identify elements of treatment plans that are tailored to the needs of patients with
stimulant use - Employ strategies to address difficulties that may occur over the course of treating
patients with stimulant use
February 9, 2022Expiration Date:
February 9, 2024
UAN #:
JA4008162-9999-22-063-H04-P
Application
Open this module→- Describe the pathophysiology of different types of pain
- Utilize tools and strategies for accurate assessment of pain
- Describe multimodal approaches to safe and effective pain management
February 11, 2021Expiration Date:
February 10, 2022
UAN #:
JA4008162-9999-21-2576-H01-P
Application
